vs
汉瑞祥（HSIC）与RYDER SYSTEM INC（R）财务数据对比。点击上方公司名可切换其他公司
汉瑞祥的季度营收约是RYDER SYSTEM INC的1.1倍（$3.4B vs $3.1B），RYDER SYSTEM INC净利率更高（3.0% vs 2.9%，领先0.0%），汉瑞祥同比增速更快（7.7% vs 1.0%），汉瑞祥自由现金流更多（$338.0M vs $273.0M），过去两年汉瑞祥的营收复合增速更高（4.1% vs -0.9%）
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
Ryder System Inc.是美国专业运输物流服务商，总部位于佛罗里达州科勒尔盖布尔斯，业务覆盖美国及英国，核心业务包含卡车租赁、车队管理、供应链及运输管理，同时提供车辆维保、二手车销售、专业司机派遣、电商履约与最后一公里配送等多元服务。
HSIC vs R — 直观对比
营收规模更大
HSIC
是对方的1.1倍
$3.1B
营收增速更快
HSIC
高出6.7%
1.0%
净利率更高
R
高出0.0%
2.9%
自由现金流更多
HSIC
多$65.0M
$273.0M
两年增速更快
HSIC
近两年复合增速
-0.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.4B | $3.1B |
| 净利润 | $101.0M | $93.0M |
| 毛利率 | 30.9% | — |
| 营业利润率 | 4.7% | — |
| 净利率 | 2.9% | 3.0% |
| 营收同比 | 7.7% | 1.0% |
| 净利润同比 | 7.4% | -5.1% |
| 每股收益（稀释后） | $0.85 | $2.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSICR
| Q1 26 | — | $3.1B | ||
| Q4 25 | $3.4B | $3.2B | ||
| Q3 25 | $3.3B | $3.2B | ||
| Q2 25 | $3.2B | $3.2B | ||
| Q1 25 | $3.2B | $3.1B | ||
| Q4 24 | $3.2B | $3.2B | ||
| Q3 24 | $3.2B | $3.2B | ||
| Q2 24 | $3.1B | $3.2B |
净利润HSICR
| Q1 26 | — | $93.0M | ||
| Q4 25 | $101.0M | $132.0M | ||
| Q3 25 | $101.0M | $138.0M | ||
| Q2 25 | $86.0M | $131.0M | ||
| Q1 25 | $110.0M | $98.0M | ||
| Q4 24 | $94.0M | $135.0M | ||
| Q3 24 | $99.0M | $142.0M | ||
| Q2 24 | $104.0M | $127.0M |
毛利率HSICR
| Q1 26 | — | — | ||
| Q4 25 | 30.9% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.4% | — | ||
| Q1 25 | 31.6% | — | ||
| Q4 24 | 31.1% | — | ||
| Q3 24 | 31.3% | — | ||
| Q2 24 | 32.5% | — |
营业利润率HSICR
| Q1 26 | — | — | ||
| Q4 25 | 4.7% | 5.6% | ||
| Q3 25 | 4.9% | 6.0% | ||
| Q2 25 | 4.7% | 5.8% | ||
| Q1 25 | 5.5% | 4.3% | ||
| Q4 24 | 4.9% | 5.7% | ||
| Q3 24 | 4.9% | 5.9% | ||
| Q2 24 | 5.1% | 5.6% |
净利率HSICR
| Q1 26 | — | 3.0% | ||
| Q4 25 | 2.9% | 4.2% | ||
| Q3 25 | 3.0% | 4.4% | ||
| Q2 25 | 2.7% | 4.1% | ||
| Q1 25 | 3.5% | 3.1% | ||
| Q4 24 | 2.9% | 4.2% | ||
| Q3 24 | 3.1% | 4.5% | ||
| Q2 24 | 3.3% | 4.0% |
每股收益（稀释后）HSICR
| Q1 26 | — | $2.34 | ||
| Q4 25 | $0.85 | $3.22 | ||
| Q3 25 | $0.84 | $3.32 | ||
| Q2 25 | $0.70 | $3.13 | ||
| Q1 25 | $0.88 | $2.27 | ||
| Q4 24 | $0.75 | $3.09 | ||
| Q3 24 | $0.78 | $3.24 | ||
| Q2 24 | $0.80 | $2.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.0M | $182.0M |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $3.2B | $2.9B |
| 总资产 | $11.2B | — |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
现金及短期投资HSICR
| Q1 26 | — | $182.0M | ||
| Q4 25 | $156.0M | $198.0M | ||
| Q3 25 | $136.0M | $189.0M | ||
| Q2 25 | $145.0M | $180.0M | ||
| Q1 25 | $127.0M | $151.0M | ||
| Q4 24 | $122.0M | $154.0M | ||
| Q3 24 | $126.0M | $162.0M | ||
| Q2 24 | $138.0M | $164.0M |
总债务HSICR
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | $6.8B | ||
| Q3 25 | $2.2B | $7.3B | ||
| Q2 25 | $2.1B | $7.0B | ||
| Q1 25 | $2.0B | $6.7B | ||
| Q4 24 | $1.8B | $6.7B | ||
| Q3 24 | $1.9B | $6.6B | ||
| Q2 24 | $1.9B | $6.5B |
股东权益HSICR
| Q1 26 | — | $2.9B | ||
| Q4 25 | $3.2B | $3.1B | ||
| Q3 25 | $3.4B | $3.1B | ||
| Q2 25 | $3.4B | $3.1B | ||
| Q1 25 | $3.3B | $3.0B | ||
| Q4 24 | $3.4B | $3.1B | ||
| Q3 24 | $3.5B | $3.1B | ||
| Q2 24 | $3.5B | $3.1B |
总资产HSICR
| Q1 26 | — | — | ||
| Q4 25 | $11.2B | $16.4B | ||
| Q3 25 | $11.1B | $16.5B | ||
| Q2 25 | $10.9B | $16.5B | ||
| Q1 25 | $10.5B | $16.4B | ||
| Q4 24 | $10.2B | $16.7B | ||
| Q3 24 | $10.6B | $16.5B | ||
| Q2 24 | $10.3B | $16.4B |
负债/权益比HSICR
| Q1 26 | — | — | ||
| Q4 25 | 0.71× | 2.24× | ||
| Q3 25 | 0.64× | 2.35× | ||
| Q2 25 | 0.61× | 2.27× | ||
| Q1 25 | 0.59× | 2.21× | ||
| Q4 24 | 0.54× | 2.14× | ||
| Q3 24 | 0.54× | 2.17× | ||
| Q2 24 | 0.54× | 2.09× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $381.0M | $583.0M |
| 自由现金流经营现金流 - 资本支出 | $338.0M | $273.0M |
| 自由现金流率自由现金流/营收 | 9.8% | 8.7% |
| 资本支出强度资本支出/营收 | 1.3% | 13.7% |
| 现金转化率经营现金流/净利润 | 3.77× | 6.27× |
| 过去12个月自由现金流最近4个季度 | $573.0M | $595.0M |
8季度趋势，按日历期对齐
经营现金流HSICR
| Q1 26 | — | $583.0M | ||
| Q4 25 | $381.0M | $749.0M | ||
| Q3 25 | $174.0M | $442.0M | ||
| Q2 25 | $120.0M | $752.0M | ||
| Q1 25 | $37.0M | $651.0M | ||
| Q4 24 | $204.0M | $558.0M | ||
| Q3 24 | $151.0M | $629.0M | ||
| Q2 24 | $296.0M | $552.0M |
自由现金流HSICR
| Q1 26 | — | $273.0M | ||
| Q4 25 | $338.0M | $344.0M | ||
| Q3 25 | $141.0M | $-85.0M | ||
| Q2 25 | $88.0M | $63.0M | ||
| Q1 25 | $6.0M | $137.0M | ||
| Q4 24 | $168.0M | $-201.0M | ||
| Q3 24 | $117.0M | $30.0M | ||
| Q2 24 | $259.0M | $-87.0M |
自由现金流率HSICR
| Q1 26 | — | 8.7% | ||
| Q4 25 | 9.8% | 10.8% | ||
| Q3 25 | 4.2% | -2.7% | ||
| Q2 25 | 2.7% | 2.0% | ||
| Q1 25 | 0.2% | 4.4% | ||
| Q4 24 | 5.3% | -6.3% | ||
| Q3 24 | 3.7% | 0.9% | ||
| Q2 24 | 8.3% | -2.7% |
资本支出强度HSICR
| Q1 26 | — | 13.7% | ||
| Q4 25 | 1.3% | 12.8% | ||
| Q3 25 | 1.0% | 16.6% | ||
| Q2 25 | 1.0% | 21.6% | ||
| Q1 25 | 1.0% | 16.4% | ||
| Q4 24 | 1.1% | 23.8% | ||
| Q3 24 | 1.1% | 18.9% | ||
| Q2 24 | 1.2% | 20.1% |
现金转化率HSICR
| Q1 26 | — | 6.27× | ||
| Q4 25 | 3.77× | 5.67× | ||
| Q3 25 | 1.72× | 3.20× | ||
| Q2 25 | 1.40× | 5.74× | ||
| Q1 25 | 0.34× | 6.64× | ||
| Q4 24 | 2.17× | 4.13× | ||
| Q3 24 | 1.53× | 4.43× | ||
| Q2 24 | 2.85× | 4.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
R
| Fleet Management Solutions | $1.5B | 47% |
| ChoiceLease | $878.0M | 28% |
| Dedicated Transportation Solutions | $553.0M | 18% |
| Commercial rental | $211.0M | 7% |
